Aier Eye Hospital

Aier Eye Hospital is one of the largest ophthalmic medical institutions in China, belonging to the ophthalmic medical services sub-sector of the healthcare industry. Its main business is to provide patients with diagnosis, treatment for various eye diseases, and ophthalmic medical services such as optometric eyeglass fitting. The company adopts a "three-level chain" business model, providing ophthalmic medical services to patients through its subordinate chain ophthalmic hospitals. So far, Aier Eye Hospital has built nearly 20 professional ophthalmic hospitals across China. Aier Eye Hospital is committed to introducing world-class ophthalmic technologies and management methods, pursuing specialization, scale, and scientific development strategies. Collaborating with domestic and international strategic partners, it jointly promotes the development of China's ophthalmic medical industry. Through continuous practice and exploration, Aier Eye Hospital has successfully explored a chain operation management model for ophthalmic hospitals that adapts to China’s national conditions and market environment while fully absorbing advanced international medical management experiences and operational methods. Leveraging advantages in talent, technology, and management, Aier Eye Hospital has rapidly enhanced its market influence and penetration through excellent diagnostic quality, high-quality medical services, and extensive market promotion at all its chain hospitals across China, making Aier Eye Hospital a nationally influential ophthalmic brand. In 2006, Aier Eye Hospital was awarded the title of "China's Most Distinctive and Powerful Ophthalmic Hospital." Its innovative and successful model has made Aier Eye Hospital one of the fastest-growing ophthalmic medical institutions in China, with its development trend being hailed by peers at home and abroad as the "Aier Phenomenon" in China's healthcare industry. In November 2006, Aier Eye Hospital successfully passed the comprehensive evaluation by the International Finance Corporation (IFC) of the World Bank Group and obtained long-term financing provided by the IFC, marking the recognition of Aier Eye's overall strength and development prospects by a renowned international financial investment institution. In both 2008 and 2009, Aier Eye Hospital was consecutively selected into the "Zero2IPO - Top 50 Most Investment-Worthy Enterprises in China."